Published in Arch Gesamte Virusforsch on January 01, 1971
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) (1972) 7.42
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
Work of a district ethical committee. Br Med J (1979) 3.64
The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
A single radial haemolysis technique for the measurement of influenza antibody. J Gen Virol (1975) 2.62
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61
Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34
Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34
New aspects of liposomes. Biochim Biophys Acta (1976) 2.27
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Organ cultures in virology. Prog Med Virol (1969) 2.21
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13
Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13
The growth of some myxoviruses in organ cultures. Br J Exp Pathol (1965) 2.05
Coronaviridae: second report. Intervirology (1978) 2.05
Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99
Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98
Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90
Attenuation of human influenza A viruses. Br Med J (1969) 1.90
Recombinant influenza-A viruses as live vaccines for man. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1971) 1.88
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21. J Hyg (Lond) (1965) 1.82
A comparative study of attenuated influenza viruses. Bull World Health Organ (1971) 1.81
An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78
Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses. Lancet (1975) 1.74
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66
Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet (1982) 1.66
Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond) (1977) 1.62
Further trials of live influenza vaccine. Br Med J (1966) 1.58
The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol (1967) 1.58
Cultivation of "difficult" viruses from patients with common colds. Br Med J (1968) 1.57
Electron microscopic observations on the entry of influenza virus into susceptible cells. J Gen Virol (1974) 1.55
Coronaviridae. Intervirology (1975) 1.55
Growth of viruses in organ cultures of intestine. Br J Exp Pathol (1970) 1.54
Measurement of antibody to influenza virus neuraminidase by single radial hemolysis in agarose gels. Infect Immun (1976) 1.50
A mathematical model of common-cold epidemics on Tristan da Cunha. J Hyg (Lond) (1971) 1.47
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45
Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health (1993) 1.43
Virulence for man of a human influenza-A virus antigenically similar to "classical" swine viruses. Lancet (1976) 1.43
Sendai virus infection of rats as a convenient model of acute respiratory infection. Vet Rec (1970) 1.42
[Serological and epidemological data on associated vaccines against measles and mumps]. Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol (1965) 1.40
The radiation dosimetry of 99Tcm-exametazime. Nucl Med Commun (1990) 1.39
Live influenza vaccines. Lancet (1983) 1.39
Prophylaxis of influenza with a synthetic isoquinoline. Lancet (1968) 1.38
Picornaviridae. Intervirology (1974) 1.36
Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man. Arch Virol (1983) 1.35
Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob Agents Chemother (1989) 1.33
The advantages of HeLa cells for isolation of rhinoviruses. J Med Microbiol (1974) 1.32
Antigenic characteristics of swine influenza virus closely related to human Hong Kong strain and results of experimental infection in volunteers. Lancet (1971) 1.31
Antibody responses to and efficacy of an inactivated spray vaccine. Bull World Health Organ (1969) 1.29
Differentiation of temperature variants of influenza A2 viruses on the basis of plaque formation. J Virol (1968) 1.28
Deficient production of leucocyte interferon (interferon-alpha) in vitro and in vivo in children with recurrent respiratory tract infections. Lancet (1981) 1.27
Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother (1987) 1.27
Titration of tuberculin, nucleic acids and viruses by haemaggregation inhibition using a "pattern" test. Br J Exp Pathol (1967) 1.26
An epidemic of influenza on Tristan da Cunha. J Hyg (Lond) (1973) 1.26
Identification of rhinovirus stran D.C. Nature (1968) 1.24
Evaluation of amantadine in artificially induced A2 and B influenza. JAMA (1970) 1.24
Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis (1987) 1.23
Skin tests with influenza virus. J Hyg (Lond) (1973) 1.22
Viruses in febrile convulsions. Lancet (1980) 1.22
Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet (1981) 1.21
Purified interferon as protection against rhinovirus infection. Br Med J (Clin Res Ed) (1982) 1.21